We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Stada gun

13 February 2017 By Neil Unmack

The German pharma company has two takeover offers, including one from private equity firm Cinven. Cutting costs or breaking up the group could create value. However, a new management team has yet to tackle low growth. Potential bidders will be loath to pay too big a premium.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)